At the current AUA Annual Meeting going on in New Orleans, there was a presentation given by Haitao Zhang and colleagues. They described their work developing a novel blood-based assay (test) for detecting androgen receptor (AR) splice variants in men with advanced prostate cancer. Their work relies on the premise that AR-V7 expression underlies resistance … Continue reading The Development of A Novel Blood Biomarker for Detecting AR-V7 and Resistance to Zytiga and Xtandi